Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    14625336 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia (iDIAPASON)
Condition: Ventilator-Associated Pneumonia
Interventions: Drug: 8 days of effective antibiotic treatment;   Drug: 15 days of effective antibiotic treatment
2 Recruiting Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia
Condition: Pneumonia, Ventilator-Associated
Interventions: Drug: Aerosolized Tobramycin or Vancomycin;   Drug: Aerosolized Placebo
3 Recruiting Aspiration in Acute Respiratory Failure Survivors
Condition: Dysphagia
Interventions: Procedure: FEES;   Procedure: BSE
4 Unknown  Reduction the Duration of Antibiotic Therapy in the Elderly (PROPAGE)
Condition: Lung Infection
Intervention: Other: procalcitonine
5 Recruiting TR-701 FA vs Linezolid for the Treatment of Nosocomial Pneumonia
Condition: Pneumonia
Interventions: Drug: TR-701 FA IV;   Drug: Linezolid
6 Completed Suitability of Antibiotic Treatment for CAP
Condition: Community Acquired Pneumonia
Interventions: Other: Intervention group;   Other: Control group
7 Completed Comparison of Antibiotic Protocols in Spine Patients With Postoperative Drains
Conditions: Surgical Wound Infection;   Spinal Deformity;   Spinal Degeneration
Intervention: Other: Antibiotic Protocol
8 Unknown  Procalcitonin and Endotoxin Sequential Levels to Optimize the Treatment of Bloodstream Infections
Condition: Infection of Bloodstream

Indicates status has not been verified in more than two years